IRVINE, Calif., Oct. 22 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, today announced that it is scheduled to make an investor presentation at the Oppenheimer 19th Annual Healthcare Conference at 1:20 p.m. ET on Tuesday, November 4, 2008. The conference is being held at the Waldorf Astoria hotel November 3-4 in New York City.
A live webcast of the Company's presentation at the conference will be available via a link provided at http://ir.endocare.com/events.cfm. An archived replay of the presentation will be available shortly after the presentation time for a period of 90 days. Web participants are encouraged to go to the Company's website (http://ir.endocare.com/events.cfm) at least 15 minutes prior to the start of the call to register, download and install any necessary audio software.
Endocare, Inc. -- http://www.endocare.com -- is an innovative medical device
company providing minimally invasive technologies for tissue and tumor
ablation. Endocare has initially concentrated on developing technologies
for the treatment of prostate cancer and believes that its proprietary
technologies have broad applications across a number of markets, including
the ablation of tumors in the kidney, lung and liver and palliative
intervention (treatment of pain associated with metastases).
Investor Contact: Media Contact:
Matt Clawson Len Hall
Allen & Caron, Inc. Allen & Caron, Inc.
(949) 474-4300 (949) 474-4300
For Additional Information:
Terrence A. Noonan, Interim CEO
Michael R. Rodriguez, CFO
|SOURCE Endocare, Inc.|
Copyright©2008 PR Newswire.
All rights reserved